Spectrum Dynamics Medical’s Post

𝗶𝗻𝗛𝗘𝗔𝗥𝗧 𝗥𝗲𝗰𝗲𝗶𝘃𝗲𝘀 𝗙𝗗𝗔 𝗖𝗹𝗲𝗮𝗿𝗮𝗻𝗰𝗲 𝗙𝗼𝗿 𝗔𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝗔𝗜-𝗗𝗿𝗶𝘃𝗲𝗻 𝗦𝗼𝗳𝘁𝘄𝗮𝗿𝗲 𝗠𝗼𝗱𝘂𝗹𝗲 𝗧𝗵𝗮𝘁 𝗢𝗽𝘁𝗶𝗺𝗶𝘇𝗲𝘀 𝗧𝗵𝗲 𝗖𝗿𝗲𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝟯𝗗 𝗠𝗼𝗱𝗲𝗹𝘀 𝗢𝗳 𝗧𝗵𝗲 𝗛𝗲𝗮𝗿𝘁 🎉 inHEART just received FDA 510(k) clearance for its game-changing AI software module. This allows fully automated segmentation of CT images to create incredibly detailed 3D cardiac models. 🫀 While this AI automation was previously available in the EU, it can now be delivered to hospitals across the US as well. The inHEART solution aims to transform cardiac ablation procedures by providing physicians with an AI-driven digital twin that maps out each patient's unique heart anatomy in advance. 📉 Early clinical evaluations are incredibly promising - inHEART has the potential to reduce VT ablation procedure times by 60% and cut VT recurrence rates by 38% compared to conventional methods. Shorter, more effective procedures could dramatically improve outcomes and patient experience. 🚀 inHEART's mission is to make world-class cardiac imaging expertise accessible to all physicians, optimizing treatment strategies for better clinical outcomes. This FDA clearance is a major milestone towards scaling their digital twin technology more widely. #cardiology #medicaldevices #electropysiology #cmmedical

🔬 Breakthrough News in Medical Imaging: Revolutionizing Giant Cell Arteritis Diagnosis! Giant Cell Arteritis (GCA) is a race against time, but advanced imaging techniques are changing the game. Our latest blog post dives into how cutting-edge technology is transforming GCA diagnosis and management. Key highlights: ✅ The power of Color Doppler Ultrasonography ✅ PET/CT scans as the new gold standard ✅ How MRI and CT angiography fit into the picture As leaders in medical imaging solutions, we're excited about these developments and their potential to improve patient outcomes. Read the full article on our blog to learn how these advancements are shaping the future of GCA care. Link in comments! https://lnkd.in/gWM2Mttq #MedicalImaging #HealthcareTech #GiantCellArteritis #Diagnostics #FreelandSystems

🫀🩻Congratulations to the team at inHEART on their latest FDA 510(k) clearance toward their new AI-enhanced #cardiac #3dmodeling program. The Cambridge, MA & Bordeaux, France teams at inHEART have developed a novel AI-enabled 3D interactive cardiac #visualization solution that serves as a #digitaltwin helping physicians better plan individual cardiac patient treatment strategies. inHEART secured 510(k) back in 2022 for their initial cardiac 3D modeling solution and now will be the first to offer a first-of-its-kind AI-powered fully automated CT #imagesegmentation capabilities supporting pre-planning and seamless integration into existing electroanatomic mapping systems. "The addition of AI automation is an important milestone as it allows us to optimize the expertise of our team and deliver our solution within hours to physicians. Our mission is to make world-class cardiac imaging expertise available to all physicians to optimize treatment strategies, improve clinical outcomes, and treat patients in a timely manner. With our new AI module, we look forward to scaling the production of inHEART's digital twin of the heart in more centers across the US.” - Todor Jeliaskov, President and CEO of inHEART #digitalhealth #cardiaccare #medicalinnovation #fdacleared

Elevate your multi-disciplinary tumor boards with Medicai, the cloud-based medical imaging platform. Seamlessly streamline collaboration, enhance decision-making, and save valuable time. https://hubs.li/Q02nWRKg0

FUJIFILM Healthcare Americas Corporation's 𝐞𝐧𝐝𝐨𝐬𝐜𝐨𝐩𝐢𝐜 𝐢𝐦𝐚𝐠𝐢𝐧𝐠 𝐝𝐞𝐭𝐞𝐜𝐭𝐢𝐨𝐧 𝐬𝐲𝐬𝐭𝐞𝐦 𝐬𝐞𝐜𝐮𝐫𝐞𝐬 510(𝐤) 𝐜𝐥𝐞𝐚𝐫𝐚𝐧𝐜𝐞 👁 Fujifilm has received #510k clearance from the #FDA for its groundbreaking #AI-based #endoscopicimaging detection system, #CADEYE. This cutting-edge technology is designed to enhance the detection of colonic lesions, including #adenomas and #polyps, during #colonoscopy procedures. 🔍 What you should know: 𝐑𝐞𝐚𝐥-𝐓𝐢𝐦𝐞 𝐃𝐞𝐭𝐞𝐜𝐭𝐢𝐨𝐧: CAD EYE operates in real-time, providing immediate insights to #endoscopists during procedures. 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐞𝐝 𝐀𝐈 𝐈𝐧𝐭𝐞𝐠𝐫𝐚𝐭𝐢𝐨𝐧: It seamlessly integrates with Fujifilm’s #ELUXEO® Endoscopic Imaging System, leveraging #AI image processing functionality. 𝐃𝐞𝐞𝐩 𝐋𝐞𝐚𝐫𝐧𝐢𝐧𝐠 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲: CAD EYE was deep-learning validated through studies using histologically confirmed polyps. 𝐈𝐧𝐜𝐫𝐞𝐚𝐬𝐞𝐝 𝐀𝐝𝐞𝐧𝐨𝐦𝐚 𝐃𝐞𝐭𝐞𝐜𝐭𝐢𝐨𝐧 𝐑𝐚𝐭𝐞𝐬: CAD EYE significantly outperforms conventional high-definition #colonoscopy without AI for screening and surveillance. 𝐒𝐞𝐚𝐦𝐥𝐞𝐬𝐬 𝐖𝐨𝐫𝐤𝐟𝐥𝐨𝐰: CAD EYE provides visual and auditory alerts to #endoscopists when polyps are detected. Congrats to the #Fujifilm team on bringing yet another great technology into this space 👏 #medtech #medicaldevice #executivesearch #recruitment #industrynews #endoscopy #gi #gastroenterology #gastrointestinal #colonoscopy #healthcare #innovation #healthtech #artificialintelligence https://lnkd.in/d9C3AaU2

🔍 Exploring the Impact of Imaging Timing on Multi-Phase CTA Quality Ever wondered how the timing of imaging can influence the quality of three-phase CTA in medical imaging? 🤔 Let's dive into it! Three-phase Computed Tomography Angiography (CTA) is a powerful tool in visualizing blood vessels in multiple stages, shedding light on arterial, venous, and delayed phases. 🌐 The timing of these phases plays a crucial role in the diagnostic accuracy and information gleaned from the images. 🚀 Arterial Phase: Precision in Motion In the arterial phase, we capture the moment when the contrast agent surges through the arteries. 🏞️ Timing is key here, as it allows us to highlight arterial abnormalities such as stenosis or occlusions with utmost precision. 🔄 Venous Phase: Mapping the Venous Landscape Moving to the venous phase, we observe the contrast agent coursing through the venous system. 🔄 Optimal timing is crucial for visualizing veins and detecting conditions like venous thrombosis, providing a comprehensive vascular map. 🕰️ Delayed Phase: Patience Rewarded The delayed phase, captured after some time post-contrast injection, offers insights into areas that take longer to enhance, like tumors stroke or regions with sluggish blood flow. ⏳ Patience in timing yields a more complete diagnostic picture. 📊 Clinical Considerations: Balancing Act In the world of medical imaging, finding the perfect balance in timing is a constant challenge. ⚖️ Clinicians carefully consider the patient's condition, the area of interest, and the specific diagnostic goals to optimize imaging timing for each unique case. 💡 Takeaway: Precision in Every Phase Understanding the nuances of imaging timing in three-phase CTA empowers healthcare professionals to unlock a wealth of information about vascular anatomy and pathology. 🧠💪 As technology evolves, so does our ability to enhance diagnostic precision and patient care. Let's continue the conversation! What are your thoughts on the impact of imaging timing in medical diagnostics? How it can impact the efficiency of the AI-based solutions for diagnosis aid tools. would love to hear your thoughts in this regard! 👇👩⚕️👨⚕️ #cta #stroke #deeplearning #segmentation

Exciting news in the medical imaging industry! SpectraWAVE, Inc., a leading innovator, has secured $50 million in Series B funding led by Johnson & Johnson Innovation and other investors. This investment will enhance SpectraWAVE’s HyperVue™ Imaging System, offering advanced intravascular imaging capabilities. Intravascular imaging, now a key treatment strategy in Europe, has gained significant recognition. HyperVue, with its DeepOCT and NIRS technologies, revolutionizes intravascular imaging, optimizing image quality and simplifying procedures. The system's exceptional image clarity and depth empower physicians during coronary stenting, supported by clinical trials published in The Lancet. CEO Eman Namati highlighted that HyperVue delivers faster, simpler imaging, improving patient outcomes. The strong U.S. launch reception has spurred this investment, driving further commercial expansion. Moreover, SpectraWAVE is developing a wire-free physiology software add-on for HyperVue, enhancing clinical decision-making in coronary artery disease treatment. Discover more about SpectraWAVE's groundbreaking HyperVue Imaging System and the recent funding round here: https://lnkd.in/dpgcu4kr Brian Sundell Eman Namati Vivek Walimbe #MedicalImaging #HealthcareInnovation #FundingNews #IntravascularImaging #ClinicalDecisions

𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲'𝘀 𝗖𝗿𝘆𝘀𝘁𝗮𝗹 𝗕𝗮𝗹𝗹: 𝗔𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝗜𝗺𝗮𝗴𝗶𝗻𝗴 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀 𝗥𝗲𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝗶𝘇𝗲 𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗖𝗮𝗿𝗲 Discover the transformative power of advanced imaging in the new article, "Exploring the Frontiers of Healthcare: Advanced Imaging Diagnostics Unleashed." This insightful exploration dives into the world of MRI, CT scans, PET imaging, and more, revealing how these technologies are shaping the future of medicine. Learn how they improve patient outcomes, and the exciting possibilities that lie ahead. ➡ https://lnkd.in/gdbFzZjG #healthcare #medicaltechnology #diagnostics #futureofmedicine #healthcareinnovation #patientcare #imagingdiagnostics #MRI #CTscans #europeanhhm #EHHM

Huge congratulations to the incredible team at See-Mode Technologies! As the first investors in See-Mode, we at Cocoon Capital couldn't be prouder to celebrate their latest milestone: receiving FDA clearance for their groundbreaking thyroid ultrasound AI analysis and reporting software. This marks a major leap in healthcare, enabling faster, more accurate diagnoses and improving the workflow for clinicians. The AI-powered solution not only enhances radiologist performance by automatically detecting and classifying thyroid nodules but also reduces reporting time and variability. This is a game-changer in streamlining care, with the potential to transform thyroid ultrasound diagnostics globally. See-Mode’s relentless dedication to revolutionising medical imaging is inspiring, and this achievement highlights their leadership in using AI to enhance clinical workflows. We're thrilled to be part of their journey from the very beginning, and we can't wait to see what they achieve next! #AIinHealthcare #MedicalInnovation #ThyroidUltrasound #FDAApproval #ProudInvestor #CocoonCapital #SeeModeTechnologies #HealthcareInnovation #daretochange

Excited to share my journey in the #ClinicalTrials landscape! 🌟 With years of experience across CROs, sponsors, and trial sites, I've gained a 360° view of our industry's challenges and triumphs. Having faced the complexities of clinical trials, I understand the pressures and relentless drive for excellence. Today, I want to highlight the significant challenges in #MedicalImaging and how Collective Minds Radiology, together with our partners, is transforming these obstacles into opportunities for innovation and progress. Check the blog below to learn more! #ClinicalTrials #MedicalImaging #Innovation #Healthcare #CollectiveMinds